Gastric bypass simultaneously improves adipose tissue function and insulin-dependent type 2 diabetes mellitus
- 210 Downloads
The underlying causes of type 2 diabetes (T2DM) remain poorly understood. Adipose tissue dysfunction with high leptin, inflammation, and increased oxidative stress may play a pivotal role in T2DM development in obese patients. Little is known about the changes in the adipose tissue after Roux-Y gastric bypass (RYGB) in non-severely obese patients (BMI < 35 kg/m2) and since these patients have more T2DM-associated complications than obese patients (“obesity paradox”), we investigated changes in adipose tissue function in a cohort of BMI <35 kg/m2 with insulin-dependent T2DM after RYGB surgery which resolves T2DM.
Twenty patients with insulin-dependent T2DM and BMI <35 kg/m2 underwent RYGB. Insulin-resistance, leptin, oxidative stress, and cytokines were determined over 24 months. Expression of cytokines and NF-kappaB pathway genes were measured in leukocytes (PBMC). Adipose tissue inflammation was examined histologically preoperatively and 24 months after RGYB in subcutaneous adipose tissue.
Insulin-resistance, leptin, oxidative stress as well as adipose tissue inflammation decreased significantly after RYGB. Similarly, systemic inflammation was reduced and peripheral blood mononuclear cells (PBMCs) were reprogrammed towards an M2-type inflammation. Loss of BMI correlated with leptin levels (r = 0.891, p < 0.0001), insulin resistance (r = 0.527, p = 0.003), and oxidative stress (r = 0.592, p = 0.016). Leptin correlated with improved insulin resistance (r = 0.449, p = 0.032) while reduced leptin showed a strong association with improved oxidative stress (r = 0.809, p = 0.001). Lastly, reduced oxidative stress correlated strongly with improved insulin-resistance (r = 0.776, p = 0.001).
RYGB improves adipose tissue function and inflammation. Leptin as marker for adipose tissue dysfunction may be the mediating factor between insulin resistance and oxidative stress and thereby likely improving T2DM.
KeywordsDiabetes T2DM Inflammation Adipose tissue Macrophages Gastric bypass RYGB
This study was supported by the German Research Society (DFG) awarded to Prof. P. Nawroth (SFB 1118).
Compliance with ethical standards
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Informed consent was obtained from all individual participants included in the study.
Statement of competing financial interests
None of the authors has any competing financial interests.
Conflict of interest
The authors declared that they have no conflict of interest.
- 3.Picot J, Jones J, Colquitt JL et al (2009) The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation. Health Technol Assess 13(41):1–190, 215–357Google Scholar
- 6.Muller-Stich BP, Senft JD, Warschkow R, et al. (2014) Surgical versus medical treatment of type 2 diabetes mellitus in nonseverely obese patients: a systematic review and meta-analysis. Ann SurgGoogle Scholar
- 8.Schauer PR, Bhatt DL, Kirwan JP, et al. (2014) Bariatric surgery versus intensive medical therapy for diabetes −3-year outcomes. N Engl J MedGoogle Scholar
- 25.Woelnerhanssen B, Peterli R, Steinert RE, Peters T, Borbely Y, Beglinger C (2011) Effects of postbariatric surgery weight loss on adipokines and metabolic parameters: comparison of laparoscopic roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy—a prospective randomized trial. Surg Obes Relat Dis 7:561–568CrossRefPubMedGoogle Scholar
- 27.Muller-Stich BP, Billeter AT, Fleming T, Fischer L, Buchler MW, Nawroth PP (2014) Nitrosative stress but not glycemic parameters correlate with improved neuropathy in nonseverely obese diabetic patients after roux-Y gastric bypass. Surg Obes Relat Dis Off J Am Soc Bariatric SurgGoogle Scholar
- 33.Billeter AT, Probst P, Fischer L, et al. (2015) Risk of malnutrition, trace metal, and vitamin deficiency post roux-en-Y gastric bypass-a prospective study of 20 patients with BMI <35 kg/m. Obes SurgGoogle Scholar
- 34.Billeter ATKS, Zeier M, Scheurlen K, Fischer L, Schulte TM, Kenngott HG, Israel B, Knefeli P, Büchler MW, Nawroth PP, Müller-Stich BP (2016) Renal function in type 2 diabetes following gastric bypass—a prospective cohort study in mildly obese insulin-dependent patients. Dtsch Arztebl Int 113:2016Google Scholar
- 37.Nguyen D (2013) Quantifying chromogen intensity in immunohistochemistry via reciprocal intensity. Protocol ExchGoogle Scholar